Previous Section | Index | Home Page |
Mr. Burstow: To ask the Secretary of State for Health what the cumulative breakeven position was in 2005 for each NHS organisation in London as reported in the final accounts of national health service trusts. [88962]
Andy Burnham [pursuant to the reply, 25 July 2006, Official Report, c. 1231-32W]: I regret my previous reply was incorrect. The final total should read (90,331) not (610,539) as given in my answer.
The revised table showing financial position of all NHS organisations in London is as follows. The data given is the break-even cumulative position of NHS trusts.
Justine Greening: To ask the Secretary of State for Health which drugs were not approved by the National Institute for Health and Clinical Excellence which were assessed to have a cost per quality-adjusted-life-year of between £30,000 and £35,000 in each year since 2000; and if she will make a statement. [87745]
Andy Burnham [holding answer 24 July 2006]: An analysis has been undertaken of drugs not approved by the National Institute for Health and Clinical Excellence (NICE), taking into account appraisals published between 1 January 2000 and 27 July 2006. Of the drugs appraised but not approved by NICE none fell exactly into the cost quality-adjusted-life-year (QALY) range of between £30,000 and £35,000, although NICEs appraisal of Anakinra for rheumatoid arthritis (published in November 2003) identified a wide potential cost per QALY range of between £20,000 and £952,000. Further information on this appraisal can be found on NICEs website at www.nice.org.uk
Anne Milton: To ask the Secretary of State for Health pursuant to the answer of 31 May 2006, Official Report, column 31W, on Small Change Big Difference; how much the campaign has cost; and how much money has been allocated for the entirety of the campaign. [79761]
Caroline Flint: The Department has spent under £1,000 on the launch of the initiative. Small Change Big Difference is the working title for our social marketing strategy for Englanda key Choosing Health commitment. The Department is currently developing the strategy over the next five years so the entire cost has yet to be determined.
Index | Home Page |